¼¼Æ÷ ¹× À¯ÀüÀÚ Ä¡·á ¹ÙÀÌ¿À ºÐ¼® ½ÃÇè ¼ºñ½º ½ÃÀå : Á¦Ç° À¯Çüº°, ½ÃÇè À¯Çüº°, ±â¼úº°, ÀûÀÀÁõº°, ÃÖÁ¾ »ç¿ëÀÚº°, ±¹°¡º°, Áö¿ªº° »ê¾÷ ºÐ¼®, ½ÃÀå ±Ô¸ð, ½ÃÀå Á¡À¯À², ¿¹Ãø(2025-2032³â)
Cell & Gene Therapy Bioanalytical Testing Services Market, By Product Type, By Test Type, By Technology, By Indication Coverage, By End User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
»ùÇà ¿äû ¸ñ·Ï¿¡ Ãß°¡
º¸°í¼ ÇÏÀ̶óÀÌÆ®
¼¼Æ÷ ¹× À¯ÀüÀÚ Ä¡·á ¹ÙÀÌ¿À ºÐ¼® ½ÃÇè ¼ºñ½º ½ÃÀå ±Ô¸ð´Â 2024³â¿¡ 5¾ï 6,090¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2025³âºÎÅÍ 2032³â¿¡ °ÉÃÄ CAGR 7.90%·Î ¼ºÀåÇÒ Àü¸ÁÀÔ´Ï´Ù.
¼¼Æ÷ ¹× À¯ÀüÀÚ Ä¡·á ¹ÙÀÌ¿À ºÐ¼® ½ÃÇè ¼ºñ½º ½ÃÀå : ½ÃÀå ¿ªÇÐ
ÀÓ»ó ½ÃÇè Áõ°¡¿Í ±ÔÁ¦ °¨µ¶ °È°¡ ½ÃÀå È®ÀåÀ» °¡¼ÓÈÇÒ °Í
ÀÓ»ó ½ÃÇè Ȱµ¿ÀÇ ±ÞÁõ°ú °í±Þ Ä¡·á¹ý¿¡ ´ëÇÑ ±ÔÁ¦ ´ç±¹ÀÇ ÁýÁßÀûÀÎ °¨µ¶Àº ¼¼Æ÷ ¹× À¯ÀüÀÚ Ä¡·á »ý¹°ÇÐÀû ºÐ¼® ½ÃÇè ¼ºñ½º¿¡ ´ëÇÑ ¼ö¿ä¸¦ Å©°Ô Áõ°¡½ÃÄ×½À´Ï´Ù. 2023³â ¹Ì±¹ ½ÄǰÀǾ౹(FDA)Àº À¯ÀüÀÚ Ä¡·áÁ¦ °ü·Ã 25°Ç ÀÌ»óÀÇ ½Å¾à ÀÓ»ó½ÃÇè ½Åû¼(IND)¸¦ ½ÂÀÎÇßÀ¸¸ç, ÀÌ´Â Æò°¡ ÁßÀÎ Ä¡·áÁ¦ ÆÄÀÌÇÁ¶óÀÎÀÇ ÅºÅºÇÔÀ» ¹Ý¿µÇÕ´Ï´Ù. ¶ÇÇÑ À¯·´ ÀǾàǰû(EMA)°ú ÀϺ» ÀǾàǰ ¹× ÀÇ·á±â±âû(PMDA) µî ±ÔÁ¦ ±â°üÀº ¾ÈÀü¼º°ú À¯È¿¼º È®º¸¸¦ À§ÇØ Æ÷°ýÀûÀÎ »ý¹°ÇÐÀû ºÐ¼® °ËÁõ Àǹ«È¸¦ °ÈÇϰí ÀÖ½À´Ï´Ù. NIH ¹× CIRM(͏®Æ÷´Ï¾Æ Àç»ý ÀÇÇÐ ¿¬±¸¼Ò)°ú °°Àº ±â°üÀº À¯ÀüÀÚ ¹× ¼¼Æ÷ ±â¹Ý ÀÓ»ó ½ÃÇè¿¡ ´ëÇÑ ÀÚ±ÝÀ» ´Ã·Á Àü¹® ½ÃÇè ¼ºñ½º¿¡ ´ëÇÑ ¼ö¿ä¸¦ °£Á¢ÀûÀ¸·Î ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µ¿ÇâÀº ƯÈ÷ ±ÔÁ¦°¡ °ÈµÇ°í Çõ½ÅÀÌ ÃËÁøµÇ´Â ¹Ì·¡¿¡ Ä¡·áÀÇ ¼º°ø°ú ½ÃÀå ½ÂÀÎÀ» À§ÇØ ÇʼöÀûÀÎ µ¥ÀÌÅÍ ¹«°á¼ºÀ» º¸ÀåÇÏ´Â µ¥ °íÁ¤¹Ð ºÐ¼® Ç÷§ÆûÀÌ Áß¿äÇÑ ¿ªÇÒÀ» ÇÑ´Ù´Â Á¡À» °Á¶ÇÕ´Ï´Ù.
¼¼Æ÷ ¹× À¯ÀüÀÚ Ä¡·á ¹ÙÀÌ¿À ºÐ¼® ½ÃÇè ¼ºñ½º ½ÃÀå : ÁÖ¿ä ÀλçÀÌÆ®
¿ì¸®ÀÇ ¸®¼Ä¡ ¾Ö³Î¸®½ºÆ®ÀÇ ºÐ¼®¿¡ µû¸£¸é ¼¼°èÀÇ ½ÃÀåÀº ¿¹Ãø ±â°£ 2025-2032³â¿¡ ¾à 7.90%ÀÇ ¿¬Æò±Õ ¼ºÀå·ü(CAGR)·Î ¸Å³â ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.
Á¦Ç° À¯Çüº°·Î, ¼¼Æ÷ Ä¡·á´Â 2024³â¿¡ ÃÖ´ë ½ÃÀå Á¡À¯À²À» º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµÇ¾ú½À´Ï´Ù.
½ÃÇè À¯Çüº°·Î´Â »ýü ÀÌ¿ë·ü ¹× »ý¹°ÇÐÀû µ¿µî¼ºÀº 2024³â¿¡ ÁÖ¿ä ½ÃÇè À¯ÇüÀ̾ú½À´Ï´Ù.
±â¼úº°·Î Â÷¼¼´ë ¿°±â¼¿ ºÐ¼®(NGS)Àº 2024³â¿¡ ÁÖ¿ä ±â¼úÀ̾ú½À´Ï´Ù.
ÀûÀÀÁõº°·Î´Â ¾ÏÀÌ 2024³âÀÇ ÁÖ¿ä ÀûÀÀÁõÀ̾ú½À´Ï´Ù.
ÃÖÁ¾ »ç¿ëÀÚº°·Î 2024³â ÁÖ¿ä ÃÖÁ¾ »ç¿ëÀÚ´Â »ý¸í°øÇÐ ¹× Á¦¾à ±â¾÷À̾ú½À´Ï´Ù.
Áö¿ªº°·Î ºÏ¹Ì´Â 2024³â ÁÖ¿ä ¼öÀÍ¿øÀÔ´Ï´Ù.
¼¼Æ÷ ¹× À¯ÀüÀÚ Ä¡·á ¹ÙÀÌ¿À ºÐ¼® ½ÃÇè ¼ºñ½º ½ÃÀå ¼¼ºÐÈ ºÐ¼® :
¼¼°èÀÇ ¼¼Æ÷ ¹× À¯ÀüÀÚ Ä¡·á ¹ÙÀÌ¿À ºÐ¼® ½ÃÇè ¼ºñ½º ½ÃÀåÀº Á¦Ç° À¯Çü, ½ÃÇè À¯Çü, ±â¼ú, ÀûÀÀÁõ, ÃÖÁ¾ »ç¿ëÀÚ, Áö¿ª¿¡ µû¶ó ±¸ºÐµË´Ï´Ù.
½ÃÀåÀº Á¦Ç° À¯Çü¿¡ µû¶ó ¼¼ °¡Áö ºÎ¹®À¸·Î ³ª´¹´Ï´Ù : ¼¼Æ÷ Ä¡·á, À¯ÀüÀÚ Ä¡·á(Ex-vivo ¹× In-vivo) ¹× À¯ÀüÀÚ º¯Çü ¼¼Æ÷ Ä¡·á(CAR T ¼¼Æ÷ Ä¡·á, CAR-NK ¼¼Æ÷ Ä¡·á, TCR-T ¼¼Æ÷ Ä¡·á). ¼¼Æ÷ Ä¡·á ¼ºñ½º´Â Áٱ⠼¼Æ÷ ¹× ¸é¿ª ¼¼Æ÷ÀÇ È¿´É, Á¤Ã¼¼º ¹× ¾ÈÀü¼º ½ÃÇè¿¡ ÁßÁ¡À» µÓ´Ï´Ù. À¯ÀüÀÚ Ä¡·á´Â »ýü ¿Ü ¹× »ýü ³» ¾ç½ÄÀ¸·Î ±¸ºÐµÇ¸ç, ¹ÙÀÌ·¯½º º¤ÅÍ ¹× Àü´Þ È¿À²¼º ºÐ¼®ÀÌ ÇÊ¿äÇÕ´Ï´Ù. CAR T, CAR-NK ¹× TCR-T¿Í °°Àº À¯ÀüÀÚ º¯Çü ¼¼Æ÷ Ä¡·á´Â °øÇÐÀûÀ¸·Î ¼³°èµÈ ¸é¿ª ¹ÝÀÀ¿¡ ´ëÇÑ »ý¹° ºÐ¼®Àû °ËÁõÀ» °Á¶ÇÕ´Ï´Ù.
½ÃÀåÀº ½ÃÇè À¯Çü¿¡ µû¶ó »ýüÀÌ¿ë·ü ¹× »ý¹°ÇÐÀû µ¿µî¼º ¿¬±¸, ¾àµ¿ÇÐ ½ÃÇè, ¾à·ÂÇÐ ½ÃÇè, ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÇè, ºñÀÓ»ó, Á¶Á÷ ¹ÙÀÌ¿À ºÐ¼®, ±âŸ·Î 8°¡Áö ¹üÁÖ·Î ³ª´¹´Ï´Ù. »ýüÀÌ¿ë·ü ¹× »ý¹°ÇÐÀû µ¿µî¼º ¿¬±¸´Â Ä¡·á Àϰü¼ºÀ» º¸ÀåÇϸç, ¾àµ¿ÇÐ ¹× ¾à·ÂÇÐ ½ÃÇè´Â Èí¼ö ¹× ¾à¹° ÀÛ¿ëÀ» Æò°¡ÇÕ´Ï´Ù. »ý¹°Ç¥ÁöÀÚ °Ë»ç´Â È¿´É ÃßÀûÀ» Áö¿øÇϸç, ºñÀÓ»ó ¹× Á¶Á÷ ¹ÙÀÌ¿À ºÐ¼®Àº ÀüÀÓ»ó ÀλçÀÌÆ®¸¦ Á¦°øÇÕ´Ï´Ù. ±âŸ ¹× ±âŸ °Ë»ç´Â Áö¿øÀûÀÌ¸ç »ç·Êº° ºÐ¼® µ¥ÀÌÅ͸¦ Á¦°øÇÕ´Ï´Ù.
¼¼Æ÷ ¹× À¯ÀüÀÚ Ä¡·á ¹ÙÀÌ¿À ºÐ¼® ½ÃÇè ¼ºñ½º ½ÃÀå : Áö¿ªÀû ÀλçÀÌÆ®
¼¼Æ÷ ¹× À¯ÀüÀÚ Ä¡·á ¹ÙÀÌ¿À ºÐ¼® ½ÃÇè ¼ºñ½º ½ÃÀåÀº Áö¿ª°£ÀÇ Ä¡·á °³¹ß ¼Óµµ, ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ© ¹× Áö¿ªº° R&D ÀÚ±Ý Áö¿ø¿¡ µû¶ó Áö¸®ÀûÀ¸·Î Å« Â÷À̸¦ º¸ÀÔ´Ï´Ù. ºÏ¹Ì´Â ÷´Ü »ý¸í °øÇÐ Çãºê, °·ÂÇÑ Á¤ºÎ Áö¿ø, Çõ½ÅÀûÀÎ Ä¡·á¹ýÀÇ Á¶±â äÅÃÀ¸·Î ½ÃÀå Á¡À¯À²¿¡¼ ¼±µÎ¸¦ ´Þ¸®°í ÀÖ½À´Ï´Ù. ƯÈ÷ ¹Ì±¹Àº À¯ÀüÀÚ ¹× ¼¼Æ÷ Ä¡·á °³¹ßÀÚµé·Î ±¸¼ºµÈ ¹ÐÁýµÈ ³×Æ®¿öÅ©¿Í FDAÀÇ ½Å¼ÓÇÑ ½ÂÀÎ ÀýÂ÷¿Í °°Àº ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©¸¦ °®Ãß°í ÀÖ¾î ÀÓ»ó È®ÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. À¯·´ÀÌ ±× µÚ¸¦ ¹Ù¦ µû¸£°í ÀÖÀ¸¸ç, µ¶ÀÏ, ¿µ±¹, ³×´ú¶õµå µî ¿©·¯ ±¹°¡µéÀÌ GMP ÀÎÁõ ½ÇÇè½Ç°ú ±¹°¡Àû ¼¼Æ÷ Ä¡·á ÀÌ´Ï¼ÅÆ¼ºê¿¡ ÅõÀÚÇϰí ÀÖ½À´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾ç Áö¿ªÀº ƯÈ÷ Áß±¹, Çѱ¹, ÀϺ»¿¡¼ Á¤ºÎ Áö¿øÀÇ »ý¸í°øÇÐ ´ÜÁö¿Í È®ÀåµÇ´Â ÀÓ»ó ÀÎÇÁ¶ó°¡ ¼ºÀåÀ» µÞ¹ÞħÇÏ¸é¼ °·ÂÇÑ °æÀïÀÚ·Î ºü¸£°Ô ºÎ»óÇϰí ÀÖ½À´Ï´Ù. Àεµ¿Í ½Ì°¡Æ÷¸£¿¡¼ ¾Æ¿ô¼Ò½Ì µ¿ÇâÀÌ Áõ°¡ÇÏ¸é¼ Áö¿ª ¼ºñ½ºÀÇ ¹Ì·¡µµ ÀçÆíµÇ°í ÀÖÀ¸¸ç, ¾Æ½Ã¾Æ´Â ºñ¿ë È¿À²ÀûÀÎ »ý¹° ºÐ¼® Å×½ºÆ® ¼ºñ½ºÀÇ Àü·«Àû Çãºê·Î ºÎ»óÇϰí ÀÖ½À´Ï´Ù.
¼¼Æ÷ ¹× À¯ÀüÀÚ Ä¡·á ¹ÙÀÌ¿À ºÐ¼® ½ÃÇè ¼ºñ½º ½ÃÀå : °æÀï ±¸µµ
¼¼Æ÷ ¹× À¯ÀüÀÚ Ä¡·á ¹ÙÀÌ¿À ºÐ¼® ½ÃÇè ¼ºñ½º ½ÃÀåÀÇ °æÀï ȯ°æÀº º¹ÀâÇÑ »ý¹°ÇÐÀû Á¦Á¦ÀÇ ºÐ¼® ´É·Â Çâ»ó¿¡ ÁÖ·ÂÇÏ´Â ¼¼°èÀÇ °è¾à ¿¬±¸ ±â°ü(CRO), Àü¹® Å×½ºÆ® ¿¬±¸¼Ò ¹× ½ÅÈï »ý¸í°øÇÐ ¼ºñ½º Á¦°ø¾÷üÀÇ Á¸Àç·Î Ư¡ÁöÀ» ¼ö ÀÖ½À´Ï´Ù. ÁÖ¿ä ±â¾÷µéÀº ±ÔÁ¦ ¹× °úÇÐÀû ¿ä±¸»çÇ×À» ÃæÁ·Çϱâ À§ÇØ ÃÖ÷´Ü ½Ã¼³, GLP/GMP ÀÎÁõ ½ÇÇè½Ç, µ¶Á¡Àû ºÐ¼® Ç÷§Æû¿¡ ÅõÀÚÇϰí ÀÖ½À´Ï´Ù. Ä¡·áÁ¦ °³¹ß¾÷ü¿Í CRO °£ÀÇ Çù·ÂÀÌ Áõ°¡Çϸç, ÀüÀÓ»ó ´Ü°èºÎÅÍ ÀÓ»ó °³¹ß±îÁö ÀÏÁ¤ ´ÜÃà°ú ±ÔÁ¦ Áؼö È®º¸¸¦ ¸ñÇ¥·Î Çϰí ÀÖ½À´Ï´Ù. ±â¾÷µéÀº ¸ÂÃãÇü È¿´É ºÐ¼®, »ýü ºÐÆ÷ ¿¬±¸, º¤ÅÍ Æ¯¼º ºÐ¼®, Â÷¼¼´ë ½ÃÄö½Ì ±â¹Ý ºÐ¼® µîÀ» ¼ºñ½º Æ÷Æ®Æú¸®¿À¿¡ Ãß°¡ÇÏ¸ç ¼ºñ½º¸¦ È®´ëÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Çмú ¹× º´¿ø ºÎ¼Ó ¿¬±¸¼Ò´Â Ãʱ⠴ܰèÀÇ ¹æ¹ý °³¹ß ¹× Ç¥ÁØÈ¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾ç Áö¿ª°ú °°Àº Áö¿ª¿¡¼´Â ÇöÁö ±â¾÷µéÀÌ ±Û·Î¹ú ÀÓ»ó ½ÃÇèÀ» À§ÇÑ ¼ºñ½º¸¦ È®´ëÇϰí ÀÖ¾î °æÀïÀÌ ½Éȵǰí ÀÖÀ¸¸ç, ÀÌ·¯ÇÑ º¯ÈÇÏ´Â ¹Ì·¡¿¡¼ À¯¿¬¼º, ±ÔÁ¦ Àü¹® Áö½Ä, ó¸® ½Ã°£ÀÌ ÁÖ¿ä Â÷º°È ¿ä¼Ò°¡ µÇ°í ÀÖ½À´Ï´Ù.
¸ñÂ÷
Á¦1Àå ¼¼Æ÷ ¹× À¯ÀüÀÚ Ä¡·á ¹ÙÀÌ¿À ºÐ¼® ½ÃÇè ¼ºñ½º ½ÃÀå °³¿ä
Á¦2Àå ÁÖ¿ä ¿ä¾à
Á¦3Àå ¼¼Æ÷ ¹× À¯ÀüÀÚ Ä¡·á ¹ÙÀÌ¿À ºÐ¼® ½ÃÇè ¼ºñ½ºÀÇ ÁÖ¿ä ½ÃÀå µ¿Çâ
½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
½ÃÀå ±âȸ
½ÃÀåÀÇ ¹Ì·¡ µ¿Çâ
Á¦4Àå ¼¼Æ÷ ¹× À¯ÀüÀÚ Ä¡·á ¹ÙÀÌ¿À ºÐ¼® ½ÃÇè ¼ºñ½º »ê¾÷ Á¶»ç
PEST ºÐ¼®
Porter's Five Forces ºÐ¼®
¼ºÀå Àü¸Á ¸ÊÇÎ
±ÔÁ¦ Ʋ ºÐ¼®
Á¦5Àå ¼¼Æ÷ ¹× À¯ÀüÀÚ Ä¡·á ¹ÙÀÌ¿À ºÐ¼® ½ÃÇè ¼ºñ½º ½ÃÀå : ³ô¾ÆÁö´Â ÁöÁ¤ÇÐÀû ±äÀåÀÇ ¿µÇâ
COVID-19 ÆÒµ¥¹ÍÀÇ ¿µÇâ
·¯½Ã¾Æ ¹× ¿ìÅ©¶óÀ̳ª ÀüÀïÀÇ ¿µÇâ
Áßµ¿ ºÐÀïÀÇ ¿µÇâ
Á¦6Àå ¼¼Æ÷ ¹× À¯ÀüÀÚ Ä¡·á ¹ÙÀÌ¿À ºÐ¼® ½ÃÇè ¼ºñ½º ½ÃÀå »óȲ
¼¼Æ÷ ¹× À¯ÀüÀÚ Ä¡·á ¹ÙÀÌ¿À ºÐ¼® ½ÃÇè ¼ºñ½º ½ÃÀå Á¡À¯À² ºÐ¼®(2024³â)
ÁÖ¿ä Á¦Á¶¾÷üº° ºÐ¼® µ¥ÀÌÅÍ
º£Å×¶û ¼±¼öÀÇ ºÐ¼®
½ÅÈï±â¾÷ÀÇ ºÐ¼®
Á¦7Àå ¼¼Æ÷ ¹× À¯ÀüÀÚ Ä¡·á ¹ÙÀÌ¿À ºÐ¼® ½ÃÇè ¼ºñ½º ½ÃÀå : Á¦Ç° À¯Çüº°
°³¿ä
ºÎ¹® Á¡À¯À² ºÐ¼® : Á¦Ç° À¯Çüº°
¼¼Æ÷ Ä¡·á
À¯ÀüÀÚ Ä¡·á
»ýü¿Ü(Ex-vivo)
»ýü³»(In-vivo)
À¯ÀüÀÚ º¯Çü ¼¼Æ÷ ¿ä¹ý
CAR T ¼¼Æ÷ ¿ä¹ý
CAR-NK ¼¼Æ÷¿ä¹ý
TCR-T ¼¼Æ÷¿ä¹ý
Á¦8Àå ¼¼Æ÷ ¹× À¯ÀüÀÚ Ä¡·á ¹ÙÀÌ¿À ºÐ¼® ½ÃÇè ¼ºñ½º ½ÃÀå : ½ÃÇè À¯Çüº°
°³¿ä
ºÎ¹® Á¡À¯À² ºÐ¼® : ½ÃÇè À¯Çüº°
»ýü ÀÌ¿ë·ü ¹× »ý¹°ÇÐÀû µ¿µî¼º ¿¬±¸
¾àµ¶ÇÐ ½ÃÇè
¾à·ÂÇÐ ½ÃÇè
¹ÙÀÌ¿À¸¶Ä¿ ½ÃÇè
ºñÀÓ»ó
Á¶Á÷ ¹ÙÀÌ¿À ºÐ¼®
±âŸ
Á¦9Àå ¼¼Æ÷ ¹× À¯ÀüÀÚ Ä¡·á ¹ÙÀÌ¿À ºÐ¼® ½ÃÇè ¼ºñ½º ½ÃÀå : ±â¼úº°
°³¿ä
ºÎ¹® Á¡À¯À² ºÐ¼® : ±â¼úº°
PCR
ELISA
Â÷¼¼´ë ½ÃÄö½Ì(NGS)
À¯¼¼Æ÷ ºÐ¼®
±âŸ
Á¦10Àå ¼¼Æ÷ ¹× À¯ÀüÀÚ Ä¡·á ¹ÙÀÌ¿À ºÐ¼® ½ÃÇè ¼ºñ½º ½ÃÀå : ÀûÀÀÁõº°
°³¿ä
ºÎ¹® Á¡À¯À² ºÐ¼® : ÀûÀÀÁõº°
¾Ï
°¨¿°Áõ
½Å°æÁúȯ
½ÉÇ÷°ü Áúȯ
¼Òȱâ Áúȯ
ÀÚ°¡¸é¿ªÁúȯ
Èñ±ÍÁúȯ
±âŸ
Á¦11Àå ¼¼Æ÷ ¹× À¯ÀüÀÚ Ä¡·á ¹ÙÀÌ¿À ºÐ¼® ½ÃÇè ¼ºñ½º ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°
°³¿ä
ºÎ¹® Á¡À¯À² ºÐ¼® : ÃÖÁ¾ »ç¿ëÀÚº°
»ý¸í°øÇÐ ¹× Á¦¾à ±â¾÷
Çмú¿¬±¸±â°ü
°è¾à¿¬±¸±â°ü(CRO)
Á¦12Àå ¼¼Æ÷ ¹× À¯ÀüÀÚ Ä¡·á ¹ÙÀÌ¿À ºÐ¼® ½ÃÇè ¼ºñ½º ½ÃÀå : Áö¿ªº°
¼Ò°³
ºÏ¹Ì
°³¿ä
ºÏ¹ÌÀÇ ÁÖ¿ä Á¦Á¶¾÷ü
¹Ì±¹
ij³ª´Ù
À¯·´
°³¿ä
À¯·´ÀÇ ÁÖ¿ä Á¦Á¶¾÷ü
µ¶ÀÏ
¿µ±¹
ÇÁ¶û½º
ÀÌÅ»¸®¾Æ
½ºÆäÀÎ
³×´ú¶õµå
½º¿þµ§
·¯½Ã¾Æ
Æú¶õµå
±âŸ
¾Æ½Ã¾ÆÅÂÆò¾ç(APAC)
°³¿ä
¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÁÖ¿ä Á¦Á¶¾÷ü
Áß±¹
Àεµ
ÀϺ»
Çѱ¹
È£ÁÖ
Àεµ³×½Ã¾Æ
ű¹
Çʸ®ÇÉ
±âŸ
¶óƾ¾Æ¸Þ¸®Ä«(LATAM)
°³¿ä
¶óƾ¾Æ¸Þ¸®Ä«ÀÇ ÁÖ¿ä Á¦Á¶¾÷ü
ºê¶óÁú
¸ß½ÃÄÚ
¾Æ¸£ÇîÆ¼³ª
ÄÝ·Òºñ¾Æ
±âŸ
Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
°³¿ä
Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ÁÖ¿ä Á¦Á¶¾÷ü
»ç¿ìµð¾Æ¶óºñ¾Æ
¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
À̽º¶ó¿¤
Æ¢¸£Å°¿¹
¾ËÁ¦¸®
ÀÌÁýÆ®
±âŸ
Á¦13Àå ÁÖ¿ä º¥´õ ºÐ¼® - ¼¼Æ÷ ¹× À¯ÀüÀÚ Ä¡·á ¹ÙÀÌ¿À ºÐ¼® ½ÃÇè ¼ºñ½º ¾÷°è
°æÀï ´ë½Ãº¸µå
°æÀïÀû º¥Ä¡¸¶Å·
°æÀïÀû Æ÷Áö¼Å´×
±â¾÷ ÇÁ·ÎÆÄÀÏ
Alliance Pharma
BioAgilytix Labs
Charles River Laboratories
Clean Cells
Covance Inc.
Eurofins Scientific
ICON plc
Intertek Group Plc
IQVIA, Inc.
KCAS Bioanalytical Services
Laboratory Corporation of America Holdings
Pharmaceutical Product Development, Inc.(Thermo Fisher Scientific Inc.)
Pharmaron
Prolytix
SGS SA
Syneos Health
Others
Á¦14Àå ¾Ö³Î¸®½ºÆ®ÀÇ Àü¹æÀ§ Àü¸Á
HBR
REPORT HIGHLIGHT
Cell & Gene Therapy Bioanalytical Testing Services Market size was valued at US$ 560.90 Million in 2024, expanding at a CAGR of 7.90% from 2025 to 2032.
The Cell & Gene Therapy Bioanalytical Testing Services Market encompasses specialized analytical services that support the development, characterization, and regulatory approval of cell and gene therapy products. Growth in this market is propelled by the rising number of clinical trials in regenerative medicine and personalized therapeutics. For instance, as of early 2024, the FDA had over 2,000 active Investigational New Drug applications for gene and cell therapy products. Increasing investments from public health bodies, like the NIH's $500 million commitment to advance gene therapy for rare diseases, further bolster demand. However, the complexity of assay development and high operational costs remain key restraints. Opportunities lie in expanding testing capabilities for viral vectors, potency assays, and biodistribution studies, especially as global regulatory agencies tighten guidelines for cell-based therapies. Additionally, partnerships between biopharma and CROs are streamlining bioanalytical workflows to enhance speed-to-market for next-gen therapies.
Cell & Gene Therapy Bioanalytical Testing Services Market- Market Dynamics
Rising Clinical Trial Volume and Regulatory Scrutiny to Accelerate Market Expansion
The surge in clinical trial activity and growing regulatory focus on advanced therapies have significantly intensified the demand for cell and gene therapy bioanalytical testing services. In 2023, the U.S. FDA approved over 25 Investigational New Drug (IND) applications for gene therapies, reflecting the robust pipeline of therapies under evaluation. Furthermore, regulatory bodies like the European Medicines Agency (EMA) and the Pharmaceuticals and Medical Devices Agency (PMDA) in Japan are increasingly mandating comprehensive bioanalytical validation for safety and efficacy assurance. Organizations such as the NIH and CIRM (California Institute for Regenerative Medicine) have increased funding for gene and cell-based trials, indirectly fueling demand for specialized testing services. These trends emphasize the critical role of high-precision analytical platforms in ensuring data integrity, which is vital for therapeutic success and market authorization, particularly in a landscape that is becoming more regulated and innovation-driven.
Cell & Gene Therapy Bioanalytical Testing Services Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 7.90% over the forecast period (2025-2032)
Based on product type segmentation, Cell therapy was predicted to show maximum market share in the year 2024
Based on Test Type segmentation, Bioavailability & bioequivalence was the leading Test Type in 2024
Based on Technology segmentation, Next-Generation Sequencing (NGS) was the leading Technology in 2024
Based on Indication Coverage segmentation, Oncology Cancer was the leading Indication Coverage in 2024
Based on end user segmentation, Biotechnology & Pharmaceutical Companies were the leading end user in 2024
On the basis of region, North America was the leading revenue generator in 2024
Cell & Gene Therapy Bioanalytical Testing Services Market- Segmentation Analysis:
The Global Cell & Gene Therapy Bioanalytical Testing Services Market is segmented on the basis of Product Type, Test Type, Technology, Indication Coverage, End User, and Region.
The market is divided into three categories based on product type: Cell Therapy, Gene Therapy (Ex-vivo, and In-vivo), and Gene-Modified Cell Therapy (CAR T-cell therapies, CAR-NK cell therapy, TCR-T cell therapy). Cell therapy services focus on potency, identity, and safety testing for stem and immune cells. Gene therapy is segmented into ex-vivo and in-vivo modalities, requiring viral vector and transduction efficiency assays. Gene-modified cell therapies like CAR T, CAR-NK, and TCR-T emphasize bioanalytical validation for engineered immune responses.
The market is divided into eight categories based on Test Type: Bioavailability & Bioequivalence Studies, Pharmacokinetic Testing, Pharmacodynamic Testing, Biomarker Testing, Non-clinical, Tissue Bioanalysis, Miscellaneous, and Others. Bioavailability & bioequivalence studies ensure therapeutic consistency, while pharmacokinetic and pharmacodynamic testing assess absorption and drug action. Biomarker testing supports efficacy tracking, and non-clinical and tissue bioanalysis aid preclinical insights. Miscellaneous and other tests provide supportive, case-specific analytical data.
Cell & Gene Therapy Bioanalytical Testing Services Market- Geographical Insights
The Cell & Gene Therapy Bioanalytical Testing Services Market shows significant geographical variation, driven by the pace of therapy development, regulatory frameworks, and R&D funding across regions. North America leads in market share due to the presence of advanced biotechnology hubs, strong government support, and early adoption of innovative therapies. The U.S., in particular, has a dense network of gene and cell therapy developers and regulatory frameworks such as the FDA's accelerated pathways, encouraging clinical expansion. Europe follows closely, with countries like Germany, the UK, and the Netherlands investing in GMP-certified labs and national cell therapy initiatives. Asia-Pacific is rapidly emerging as a strong contender, especially in China, South Korea, and Japan, where government-backed biotech parks and expanding clinical infrastructure support growth. Increasing outsourcing trends in India and Singapore are also reshaping the regional service landscape, making Asia a strategic hub for cost-effective bioanalytical testing services.
Cell & Gene Therapy Bioanalytical Testing Services Market- Competitive Landscape:
The competitive landscape of the Cell & Gene Therapy Bioanalytical Testing Services Market is marked by the presence of global contract research organizations (CROs), specialized testing labs, and emerging biotech service providers focused on advancing analytical capabilities for complex biologics. Key players are investing in state-of-the-art facilities, GLP/GMP-certified labs, and proprietary assay platforms to meet growing regulatory and scientific demands. Collaborations between therapy developers and CROs are increasing, aiming to streamline timelines and ensure regulatory compliance from preclinical stages through clinical development. Companies are expanding service portfolios to include customized potency assays, biodistribution studies, vector characterization, and next-generation sequencing-based analytics. Moreover, academic and hospital-affiliated labs are contributing to early-stage method development and standardization. Competition is also intensifying in regions like Asia-Pacific, where local firms are scaling up offerings for global trials, making flexibility, regulatory expertise, and turnaround time key differentiators in this evolving landscape.
Recent Developments:
In August 2024, SGS launched specialized bioanalytical testing services for cell and gene therapy in North America, offering comprehensive solutions from discovery to phase 3 clinical trials at its Hudson, New Hampshire lab, expanding global capabilities for advanced therapeutic development and regulatory compliance.
In March 2025, Bharat Biotech launched its first cell and gene therapy facility in Telangana, investing $75 million. The company aims to introduce novel cell and gene therapies for oncology and rare diseases by 2028, focusing on affordability and expanding beyond vaccines.
In April 2025, Cell Therapies and Xellera Therapeutics partnered to accelerate cell and gene therapy access across Asia-Pacific, focusing on GMP manufacturing, regulatory solutions, and collaborative innovation in Australia and Hong Kong, aiming to enhance patient care and streamline market access.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL CELL & GENE THERAPY BIOANALYTICAL TESTING SERVICES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
Alliance Pharma
BioAgilytix Labs
Charles River Laboratories
Clean Cells
Covance Inc.
Eurofins Scientific
ICON plc
Intertek Group Plc
IQVIA, Inc.
KCAS Bioanalytical Services
Laboratory Corporation of America Holdings
Pharmaceutical Product Development, Inc. (Thermo Fisher Scientific Inc.)
Pharmaron
Prolytix
SGS SA
Syneos Health
Others
GLOBAL CELL & GENE THERAPY BIOANALYTICAL TESTING SERVICES MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032
Cell Therapy
Gene Therapy
Ex-vivo
In-vivo
Gene-Modified Cell Therapy
CAR T-cell therapies
CAR-NK cell therapy
TCR-T cell therapy
GLOBAL CELL & GENE THERAPY BIOANALYTICAL TESTING SERVICES MARKET, BY TEST TYPE- MARKET ANALYSIS, 2019 - 2032
Bioavailability & Bioequivalence Studies
Pharmacokinetic Testing
Pharmacodynamic Testing
Biomarker Testing
Non-clinical
Tissue Bioanalysis
Miscellaneous
Others
GLOBAL CELL & GENE THERAPY BIOANALYTICAL TESTING SERVICES MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032
PCR
ELISA
Next-Generation Sequencing (NGS)
Flow Cytometry
Others
GLOBAL CELL & GENE THERAPY BIOANALYTICAL TESTING SERVICES MARKET, BY INDICATION COVERAGE- MARKET ANALYSIS, 2019 - 2032
Oncology Cancer
Infectious Diseases
Neurological disorders
Cardiovascular Disorders
Gastrointestinal Diseases
Autoimmune Diseases
Rare Diseases
Others
GLOBAL CELL & GENE THERAPY BIOANALYTICAL TESTING SERVICES MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032
Biotechnology & Pharmaceutical Companies
Academic & Research Institutes
Contract Research Organizations (CROs)
GLOBAL CELL & GENE THERAPY BIOANALYTICAL TESTING SERVICES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
The Netherlands
Sweden
Russia
Poland
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Australia
Indonesia
Thailand
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
UAE
Israel
Turkey
Algeria
Egypt
Rest of MEA
Table of Contents
1. Cell & Gene Therapy Bioanalytical Testing Services Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Cell & Gene Therapy Bioanalytical Testing Services Market Snippet by Product Type
2.1.2. Cell & Gene Therapy Bioanalytical Testing Services Market Snippet by Test Type
2.1.3. Cell & Gene Therapy Bioanalytical Testing Services Market Snippet by Technology
2.1.4. Cell & Gene Therapy Bioanalytical Testing Services Market Snippet by Indication Coverage
2.1.5. Cell & Gene Therapy Bioanalytical Testing Services Market Snippet by End User
2.1.6. Cell & Gene Therapy Bioanalytical Testing Services Market Snippet by Country
2.1.7. Cell & Gene Therapy Bioanalytical Testing Services Market Snippet by Region
2.2. Competitive Insights
3. Cell & Gene Therapy Bioanalytical Testing Services Key Market Trends
3.1. Cell & Gene Therapy Bioanalytical Testing Services Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Cell & Gene Therapy Bioanalytical Testing Services Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Cell & Gene Therapy Bioanalytical Testing Services Market Opportunities
3.4. Cell & Gene Therapy Bioanalytical Testing Services Market Future Trends
4. Cell & Gene Therapy Bioanalytical Testing Services Industry Study
4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Cell & Gene Therapy Bioanalytical Testing Services Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Cell & Gene Therapy Bioanalytical Testing Services Market Landscape
6.1. Cell & Gene Therapy Bioanalytical Testing Services Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players' Analysis
6.2.2. Emerging Players' Analysis
7. Cell & Gene Therapy Bioanalytical Testing Services Market - By Product Type
7.1. Overview
7.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
7.1.2. Cell Therapy
7.1.3. Gene Therapy
7.1.3.1. Ex-vivo
7.1.3.2. In-vivo
7.1.4. Gene-Modified Cell Therapy
7.1.4.1. CAR T-cell therapies
7.1.4.2. CAR-NK cell therapy
7.1.4.3. TCR-T cell therapy
8. Cell & Gene Therapy Bioanalytical Testing Services Market - By Test Type
8.1. Overview
8.1.1. Segment Share Analysis, By Test Type, 2024 & 2032 (%)
8.1.2. Bioavailability & Bioequivalence Studies
8.1.3. Pharmacokinetic Testing
8.1.4. Pharmacodynamic Testing
8.1.5. Biomarker Testing
8.1.6. Non-clinical
8.1.7. Tissue Bioanalysis
8.1.8. Miscellaneous
8.1.9. Others
9. Cell & Gene Therapy Bioanalytical Testing Services Market - By Technology
9.1. Overview
9.1.1. Segment Share Analysis, By Technology, 2024 & 2032 (%)
9.1.2. PCR
9.1.3. ELISA
9.1.4. Next-Generation Sequencing (NGS)
9.1.5. Flow Cytometry
9.1.6. Others
10. Cell & Gene Therapy Bioanalytical Testing Services Market - By Indication Coverage
10.1. Overview
10.1.1. Segment Share Analysis, By Indication Coverage, 2024 & 2032 (%)
10.1.2. Oncology Cancer
10.1.3. Infectious Diseases
10.1.4. Neurological disorders
10.1.5. Cardiovascular Disorders
10.1.6. Gastrointestinal Diseases
10.1.7. Autoimmune Diseases
10.1.8. Rare Diseases
10.1.9. Others
11. Cell & Gene Therapy Bioanalytical Testing Services Market - By End User
11.1. Overview
11.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
11.1.2. Biotechnology & Pharmaceutical Companies
11.1.3. Academic & Research Institutes
11.1.4. Contract Research Organizations (CROs)
12. Cell & Gene Therapy Bioanalytical Testing Services Market- By Geography
12.1. Introduction
12.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
12.2. North America
12.2.1. Overview
12.2.2. Cell & Gene Therapy Bioanalytical Testing Services Key Manufacturers in North America
12.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.2.5. North America Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.2.6. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.2.7. North America Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
12.2.8. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.2.9. U.S.
12.2.9.1. Overview
12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.2.9.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.2.9.4. U.S. Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.2.9.5. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.2.9.6. U.S. Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
12.2.9.7. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.2.10. Canada
12.2.10.1. Overview
12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.2.10.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.2.10.4. Canada Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.2.10.5. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.2.10.6. Canada Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
12.2.10.7. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3. Europe
12.3.1. Overview
12.3.2. Cell & Gene Therapy Bioanalytical Testing Services Key Manufacturers in Europe
12.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.5. Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.3.6. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.7. Europe Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
12.3.8. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.9. Germany
12.3.9.1. Overview
12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.9.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.9.4. Germany Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.3.9.5. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.9.6. Germany Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
12.3.9.7. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.10. UK
12.3.10.1. Overview
12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.10.3. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.10.4. UK Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.3.10.5. UK Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.10.6. UK Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
12.3.10.7. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.11. France
12.3.11.1. Overview
12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.11.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.11.4. France Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.3.11.5. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.11.6. France Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
12.3.11.7. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.12. Italy
12.3.12.1. Overview
12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.12.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.12.4. Italy Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.3.12.5. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.12.6. Italy Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
12.3.12.7. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.13. Spain
12.3.13.1. Overview
12.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.13.3. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.13.4. Spain Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.3.13.5. Spain Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.13.6. Spain Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
12.3.13.7. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.14. The Netherlands
12.3.14.1. Overview
12.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.14.3. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.14.4. The Netherlands Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.3.14.5. The Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.14.6. The Netherlands Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
12.3.14.7. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.15. Sweden
12.3.15.1. Overview
12.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.15.3. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.15.4. Sweden Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.3.15.5. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.15.6. Sweden Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
12.3.15.7. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.16. Russia
12.3.16.1. Overview
12.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.16.3. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.16.4. Russia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.3.16.5. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.16.6. Russia Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
12.3.16.7. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.17. Poland
12.3.17.1. Overview
12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.17.3. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.17.4. Poland Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.3.17.5. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.17.6. Poland Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
12.3.17.7. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.18. Rest of Europe
12.3.18.1. Overview
12.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.18.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.18.4. Rest of the Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.3.18.5. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.18.6. Rest of the Europe Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
12.3.18.7. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4. Asia Pacific (APAC)
12.4.1. Overview
12.4.2. Cell & Gene Therapy Bioanalytical Testing Services Key Manufacturers in Asia Pacific
12.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.4.4. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.5. APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.4.6. APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.7. APAC Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
12.4.8. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.9. China
12.4.9.1. Overview
12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.9.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.9.4. China Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.4.9.5. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.9.6. China Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
12.4.9.7. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.10. India
12.4.10.1. Overview
12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.10.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.10.4. India Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.4.10.5. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.10.6. India Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
12.4.10.7. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.11. Japan
12.4.11.1. Overview
12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.11.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.11.4. Japan Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.4.11.5. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.11.6. Japan Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
12.4.11.7. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.12. South Korea
12.4.12.1. Overview
12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.12.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.12.4. South Korea Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.4.12.5. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.12.6. South Korea Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
12.4.12.7. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.13. Australia
12.4.13.1. Overview
12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.13.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.13.4. Australia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.4.13.5. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.13.6. Australia Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
12.4.13.7. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.14. Indonesia
12.4.14.1. Overview
12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.14.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.14.4. Indonesia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.4.14.5. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.14.6. Indonesia Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
12.4.14.7. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.15. Thailand
12.4.15.1. Overview
12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.15.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.15.4. Thailand Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.4.15.5. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.15.6. Thailand Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
12.4.15.7. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.16. Philippines
12.4.16.1. Overview
12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.16.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.16.4. Philippines Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.4.16.5. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.16.6. Philippines Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
12.4.16.7. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.17. Rest of APAC
12.4.17.1. Overview
12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.17.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.17.4. Rest of APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.4.17.5. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.17.6. Rest of APAC Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
12.4.17.7. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5. Latin America (LATAM)
12.5.1. Overview
12.5.2. Cell & Gene Therapy Bioanalytical Testing Services Key Manufacturers in Latin America
12.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.5.4. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.5.5. LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.5.6. LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.5.7. LATAM Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
12.5.8. LATAM Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.9. Brazil
12.5.9.1. Overview
12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.9.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.5.9.4. Brazil Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.5.9.5. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.5.9.6. Brazil Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
12.5.9.7. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.10. Mexico
12.5.10.1. Overview
12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.10.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.5.10.4. Mexico Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.5.10.5. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.5.10.6. Mexico Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
12.5.10.7. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.11. Argentina
12.5.11.1. Overview
12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.11.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.5.11.4. Argentina Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.5.11.5. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.5.11.6. Argentina Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
12.5.11.7. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.12. Colombia
12.5.12.1. Overview
12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.12.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.5.12.4. Colombia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.5.12.5. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.5.12.6. Colombia Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
12.5.12.7. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.13. Rest of LATAM
12.5.13.1. Overview
12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.13.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.5.13.4. Rest of LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.5.13.5. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.5.13.6. Rest of LATAM Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
12.5.13.7. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6. Middle East and Africa
12.6.1. Overview
12.6.2. Cell & Gene Therapy Bioanalytical Testing Services Key Manufacturers in Middle East and Africa
12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.5. Middle East and Africa Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.6.6. Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.7. Middle East and Africa Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
12.6.8. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.9. Saudi Arabia
12.6.9.1. Overview
12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.9.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.9.4. Saudi Arabia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.6.9.5. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.9.6. Saudi Arabia Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
12.6.9.7. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.10. United Arab Emirates
12.6.10.1. Overview
12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.10.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.10.4. United Arab Emirates Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.6.10.5. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.10.6. United Arab Emirates Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
12.6.10.7. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.11. Israel
12.6.11.1. Overview
12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.11.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.11.4. Israel Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.6.11.5. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.11.6. Israel Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
12.6.11.7. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.12. Turkey
12.6.12.1. Overview
12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.12.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.12.4. Turkey Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.6.12.5. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.12.6. Turkey Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
12.6.12.7. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.13. Algeria
12.6.13.1. Overview
12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.13.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.13.4. Algeria Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.6.13.5. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.13.6. Algeria Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
12.6.13.7. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.14. Egypt
12.6.14.1. Overview
12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.14.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.14.4. Egypt Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.6.14.5. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.14.6. Egypt Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
12.6.14.7. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.15. Rest of MEA
12.6.15.1. Overview
12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.15.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.15.4. Rest of MEA Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.6.15.5. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.15.6. Rest of MEA Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
12.6.15.7. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
13. Key Vendor Analysis- Cell & Gene Therapy Bioanalytical Testing Services Industry
13.1. Competitive Dashboard
13.1.1. Competitive Benchmarking
13.1.2. Competitive Positioning
13.2. Company Profiles
13.2.1. Alliance Pharma
13.2.2. BioAgilytix Labs
13.2.3. Charles River Laboratories
13.2.4. Clean Cells
13.2.5. Covance Inc.
13.2.6. Eurofins Scientific
13.2.7. ICON plc
13.2.8. Intertek Group Plc
13.2.9. IQVIA, Inc.
13.2.10. KCAS Bioanalytical Services
13.2.11. Laboratory Corporation of America Holdings
13.2.12. Pharmaceutical Product Development, Inc. (Thermo Fisher Scientific Inc.)
13.2.13. Pharmaron
13.2.14. Prolytix
13.2.15. SGS SA
13.2.16. Syneos Health
13.2.17. Others
14. 360 Degree Analyst View
15. Appendix
15.1. Research Methodology
15.2. References
15.3. Abbreviations
15.4. Disclaimer
15.5. Contact Us